agilon health, inc.AGLEarnings & Financial Report
NYSE
NextMar 31, 2026
AGL Q3 2025 Key Financial Metrics
Revenue
$1.4B
Gross Profit
N/A
Operating Profit
$-131.3M
Net Profit
$-110.2M
Gross Margin
N/A
Operating Margin
-9.1%
Net Margin
-7.7%
YoY Growth
-1.1%
Financial Flow
agilon health, inc. Q3 2025 Financial Summary
agilon health, inc. reported revenue of $1.4B for Q3 2025, with a net profit of $-110.2M (-7.7% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $1.4B |
|---|---|
| Net Profit | $-110.2M |
| Gross Margin | N/A |
| Operating Margin | -9.1% |
| Report Period | Q3 2025 |
agilon health, inc. Annual Revenue by Year
agilon health, inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $6.1B).
| Year | Annual Revenue |
|---|---|
| 2024 | $6.1B |
| 2023 | $4.3B |
| 2022 | $2.7B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $815.5M | $1.60B | $1.48B | $1.45B | $1.52B | $1.53B | $1.39B | $1.44B |
| YoY Growth | 18.2% | 41.2% | 29.0% | 19.4% | 86.7% | -4.5% | -5.9% | -1.1% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.74B | $2.32B | $2.16B | $2.09B | $1.73B | $1.93B | $1.71B | $1.60B |
| Liabilities | $1.08B | $1.63B | $1.49B | $1.52B | $1.26B | $1.43B | $1.30B | $1.29B |
| Equity | $661.8M | $689.3M | $676.6M | $574.9M | $471.0M | $500.3M | $408.9M | $306.1M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-61.2M | $-47.8M | $-18.7M | $-7.7M | $16.4M | $-32.0M | $-35.1M | $-18.2M |